The effect of topically applied salicylic compounds on serotonin-induced scratching behaviour in hairless rats

Experimental Dermatology

Volumn 11, Issue 4, 2002, Pages 370-375

  Thomsen, J S ^a   Simonsen, L ^b   Benfeldt, E ^d   Jensen, S B ^b   Serup, J ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

Animal model; Pruritus; Salicyclic acid compounds; Skin penetration

Indexed keywords

BUTYLSALICYLATE; DIETHYLAMINE SALICYLATE; DRUG VEHICLE; SALICYLAMIDE; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; SEROTONIN; UNCLASSIFIED DRUG; ANTIPRURITIC AGENT; SALICYLAMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; FEMALE; NONHUMAN; PRURITUS; RAT; RAT STRAIN; SCRATCHING; SKIN PENETRATION; SLOW DRUG RELEASE; TOPICAL TREATMENT; VIDEORECORDING; ANIMAL; CHEMICALLY INDUCED DISORDER; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIPRURITICS; FEMALE; PRURITUS; RATS; RATS, MUTANT STRAINS; SALICYLAMIDES; SALICYLATES; SALICYLIC ACID; SALICYLIC ACIDS; SEROTONIN;

EID: 0036688998     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110412.x     Document Type: Article

References (19)

1. Fjellner B, Hagermark O. Pruritus in polycythemia vera: Treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol 1979: 59: 505-512.
2. Hagermark O. Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol 1973: 53: 363-368.
3. Daly B M, Shuster S. Effect of aspirin on pruritus. Br Med J (Clin Res Ed) 1986: 293: 907.
4. Yosipovitch G, Ademola J, Lui P, Amin S, Maibach H I. Topically applied aspirin rapidly decreases histamine-induced itch. Acta Derm Venereol 1997: 77: 46-48.
5. Steen K H, Reeh P W, Kreysel H W. Topical acetylsalicylic, salicylic acid and indomethacin suppress pain from experimental tissue acidosis in human skin. Pain 1995: 62: 339-347.
6. Schmelz M, Kress M. Topical acetylsalicylate attenuates capsaicin induced pain, flare and allodynia but not thermal hyperalgesia. Neurosci Lett 1996: 214: 72-74.
7. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: A double-blind crossover placebo-controlled study [see comments]. Pain 1996: 65: 45-51.
8. Schmelz M, Weber S, Kress M. Topical acetyl salicylate and dipyrone attenuate neurogenic protein extravasation in rat skin in vivo. Neurosci Lett 2000: 290: 57-60.
9. Lin A N, Nakatsui T. Salicyclic acid revisited. Int J Dermatol 1998: 37: 335-342.
10. Simonsen L, Therkildsen J, Jørgensen A. In vivo permeation and metabolism of salicyclic compounds in hairless rat skin. Int J Pharm 2002 (in press).
11. Simonsen L. Percutaneous absorption of salicyclic compounds. A comparison of skin penetration/permeation techniques. Thesis, 2001. University of Copenhagen, Faculty of Health Sciences.
12. Thomsen J S. Itch models and effect of topical antipruritic substances. Thesis, 2001, University of Copenhagen, Faculty of Health Sciences.
13. Thomsen J S, Petersen M B, Benfeldt E, Jensen S B, Serup J. Scratch induction in the rat by intradermal serotonin: A model for pruritus. Acta Derm Venereol 2001: 81: 250-254.
14. Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicyclic acid in hairless rats: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999: 291: 517-526.
15. Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicyclic acid penetration in human skin: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999: 140: 739-748.
16. Cross S E, Anderson C, Roberts M S. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol 1998: 46: 29-35.
17. Weisshaar E, Ziethen B, Gollnick H. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res 1997: 46: 412-416.
18. Bergasa N V. The pruritus of cholestasis. Semin Dermatol 1995: 14: 302-312.
19. Balaskas E V, Bamihas G I, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients. Nephron 1998: 78: 395-402.